The IHCV team provides expertise in a broad range of fields, including the medical, business and legal fields. An advisory panel of medical and business leaders from a wide range of health related disciplines provides support to the management team. This has created a highly effective platform for generating deal flow, assessing the scientific, commercial and investment viability of potential transactions, as well as executing transactions, creating value in portfolio companies, and facilitating exits.
Dr. Ron serves as an active chairman of the Board of several healthcare companies and is a board member of numerous others. In addition Dr. Ron serves as a member of the Board of Yissum, the technology transfer company of the Hebrew University in Jerusalem and as a member of the advisory Board of the Momentum Fund of Tel Aviv University
Dr. Ron is a physician and attorney by education.
She holds MD and LLB degrees from Tel Aviv University and has studied at the School of Business Administration at Tel Aviv University
Prior to IHCV, Eran was a consultant in McKinsey & Company, serving clients in the Pharmaceuticals, Telecommunications, and Public sectors on strategic and operational matters, in Israel, Europe, and the US. Before that Eran was a member of the Global Marketing group at Novartis Oncology, and a Quantitative Analyst at D.E. Shaw & Co. Before moving to private sector, Eran served in the Israeli Ministry of Justice, at the High Court of Justice Division, and as a Senior Advisor to the Director General of the Ministry.
Eran has an MBA from Columbia University with a major in Finance, an LL.B. in Law from Tel Aviv University, and a B.Sc. in Mathematics and Computer Science from Tel Aviv University.
Alona holds a Ph.D. in Molecular Biology and Biochemistry from the Hebrew University of Jerusalem, a M.Sc. in Life Sciences from the Weizmann Institute of Science, and a B.Sc. from the Hebrew University of Jerusalem (Magna Cum Laude).
Daniella holds a BA degree from Tel Aviv University.